このパッケージに含まれるもの
医療処置
- CAR-T細胞療法
- 24時間看護サービス
- 栄養士による1日3食
- 腫瘍血液専門医との診察
期間
- 21 日 病院で
- 7 日 ホテルで
宿泊
入院
交通
空港－クリニック－空港間の送迎
追加情報
CAR-T Therapy at Sheba Medical Center
Sheba Medical Center is a global leader in CAR-T cell therapy, offering advanced, personalized treatment for a wide range of hematologic cancers, including:
Non-Hodgkin lymphomas (DLBCL, FL, MCL), primary CNS lymphoma, ALL, CLL/Richter’s transformation, Burkitt lymphoma, and multiple myeloma.
A Fast, Fully Integrated CAR-T Process
At Sheba, the entire CAR-T procedure is performed on-site, ensuring speed, precision, and optimal cell quality.
The process includes three key steps:
Apheresis – collection of the patient’s T-cells
Cell Engineering – genetic modification at the Advanced Biotherapy Center
Infusion – reintroduction of modified cells to target cancer
Unlike many centers, Sheba does not send cells abroad. This allows treatment to be completed in approximately 10 days, making CAR-T a true “living drug” capable of long-term remission.
All patients are evaluated and treated under the supervision of Prof. Arnon Nagler, a global leading expert in hemato-oncology.
Why Choose Sheba for CAR-T
Rapid access – on-site production reduces waiting time from weeks to ~10 days
Extensive experience – largest CAR-T program in Israel and the region
Dedicated CAR-T units – for both adults and children, with 24/7 monitoring
Multidisciplinary care – hematology, oncology, immunology experts working together
Global patient services – full support with medical coordination and travel logistics
Clinical Excellence & Outcomes
Sheba is a global leader in pediatric CAR-T, with no strict age limitations for pediatric patients. Reported outcomes show:
~90% remission in pediatric patients
~80% in young adults (up to 23 years)
~70% in adults
Comprehensive Evaluation & Support
Each patient undergoes a thorough diagnostic work-up, including:
physician consultations, advanced imaging (CT, ultrasound, nuclear medicine), bone marrow biopsy, genetic and molecular testing (FISH, karyotyping), cardiac and pulmonary evaluation, and laboratory testing.
Services are provided in English, Russian, and Arabic, ensuring a smooth and supportive experience for international patients.
Key Advantage
By combining in-house cell manufacturing, leading expertise, and integrated care, Sheba delivers one of the fastest, most advanced, and most personalized CAR-T programs in the world.
24時間年中無休Bookimedサポート
- 専任医療コーディネーター
- 医療旅行手配 — 特別パートナー価格での航空券・ホテル予約
- 医療旅行中の患者擁護
プログラム料金
このパッケージに含まれないもの
医師
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
調子はいかがですか？
クリニックについて
シェバ医療センターはイスラエルおよび世界有数の病院の一つです。 ニューズウィーク・インターナショナル誌は、Sheba Hospitalを2020年の世界トップ10病院にランク付けしました。同病院は1,990の専門分野をカバーしており、毎年世界中から1,500,000人を超える患者がシェバ病院を受診しています。
支払い・特典
当社サービスへのお支払いはありません
クリニックで直接またはその公式銀行口座にお支払いいただきます。
一部のクリニックでは保証金が必要な場合があります。
分割払いオプションでお支払いを分散してください。
Bookimedにお友達を紹介して報酬を獲得してください。